XTAE
PULS
Market cap39mUSD
May 20, Last price
279.20ILS
1D
0.61%
1Q
-26.10%
IPO
-83.90%
Name
Pulsenmore Ltd
Chart & Performance
P/E
—
P/S
1,458.79
EPS
—
Div Yield, %
—
Shrs. gr., 5y
2.28%
Rev. gr., 5y
%
Revenues
10m
+56.12%
Net income
-37m
L-37.28%
CFO
-41m
L-16.52%
Profile
Pulsenmore Ltd. engages in the provision of self-scan ultrasound devices for remote clinical diagnosis and screening. The company's Pulsenmore home ultrasound system includes handheld ultrasound cradle dock with the patient's smartphone running Pulsenmore mobile app to provide two-dimensional diagnostic ultrasound imaging in fetal/obstetric applications. Its cloud based Pulsenmore software aids in the acquisition, display, and/or optimization of ultrasound images for review by healthcare professionals in a remote access setup. The company was incorporated in 2014 and is based in Omar, Israel.
Valuation
Title ILS in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | |
| Income | ||||||
Revenues | 9,661 56.12% | 6,188 -42.78% | 10,814 585.30% | |||
Cost of revenue | 35,565 | 44,445 | 43,820 | |||
Unusual Expense (Income) | ||||||
NOPBT | (25,904) | (38,257) | (33,006) | |||
NOPBT Margin | ||||||
Operating Taxes | (56) | 127 | 13,881 | |||
Tax Rate | ||||||
NOPAT | (25,848) | (38,384) | (46,887) | |||
Net income | (36,736) -37.28% | (58,567) 164.78% | (22,119) -13.68% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 3 | 2 | 51,172 | |||
BB yield | 0.00% | 0.00% | -13.28% | |||
| Debt | ||||||
Debt current | 999 | 923 | 863 | |||
Long-term debt | 3,239 | 5,737 | 7,069 | |||
Deferred revenue | 22,897 | 22,732 | ||||
Other long-term liabilities | 6,661 | 29,351 | 6,144 | |||
Net debt | (99,785) | (135,061) | (175,245) | |||
| Cash flow | ||||||
Cash from operating activities | (41,461) | (49,664) | (27,523) | |||
CAPEX | (509) | (3,926) | (4,506) | |||
Cash from investing activities | 58,581 | 56,707 | (124,554) | |||
Cash from financing activities | (1,564) | (1,144) | 50,967 | |||
FCF | (25,692) | (40,234) | (62,068) | |||
| Balance | ||||||
Cash | 104,023 | 141,721 | 183,177 | |||
Long term investments | ||||||
Excess cash | 103,540 | 141,412 | 182,636 | |||
Stockholders' equity | (167,286) | (130,550) | (64,759) | |||
Invested Capital | 295,850 | 295,463 | 285,119 | |||
ROIC | ||||||
ROCE | ||||||
| EV | ||||||
Common stock shares outstanding | 51,277 | 51,375 | 48,085 | |||
Price | 4.67 -34.37% | 7.11 -11.28% | 8.01 -42.65% | |||
Market cap | 239,209 -34.49% | 365,170 -5.21% | 385,255 -33.28% | |||
EV | 139,424 | 230,109 | 210,010 | |||
EBITDA | (23,052) | (35,854) | (31,710) | |||
EV/EBITDA | ||||||
Interest | 502 | 586 | 323 | |||
Interest/NOPBT | ||||||